XML 18 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated statements of financial position - AUD ($)
Jun. 30, 2021
Jun. 30, 2020
Current assets    
Cash and cash equivalents $ 27,586,760 $ 8,764,044
Trade and other receivables 84,000 1,352,000
Other 1,720,000 537,000
Total current assets 29,391,000 10,653,000
Non-current assets    
Trade and other receivables 6,694,000  
Intangibles 22,003,000 12,410,000
Total non-current assets 28,697,000 12,410,000
Total assets 58,088,000 23,063,000
Current liabilities    
Trade and other payables 4,933,000 3,489,000
Employee benefits 229,000 191,000
Contingent consideration 3,165,000 1,387,000
Total current liabilities 8,327,000 5,067,000
Non-Current liabilities    
Deferred tax 2,928,000 3,413,000
Employee benefits 55,000  
Contingent consideration 8,927,000 458,000
Total non-current liabilities 11,910,000 3,871,000
Total liabilities 20,237,000 8,938,000
Net assets 37,851,000 14,125,000
Equity    
Contributed equity 80,290,062 48,781,214
Other contributed equity 464,000 464,000
Reserves 1,301,000 1,066,000
Accumulated losses (44,204,000) (36,186,000)
Equity attributable to the owners of Kazia Therapeutics Limited 37,851,000 14,125,000
Total equity $ 37,851,000 $ 14,125,000